Surgical Management of Fibrolamellar Hepatocellular Carcinoma in Children Versus Adults
Journal of Surgical Oncology · 2026-11-09
DOI: 10.1002/jso.70452 ↗Abstract
ABSTRACT Background Fibrolamellar hepatocellular carcinoma (FL‐HCC) is a rare liver malignancy affecting predominantly young patients, though management can differ between pediatric and adult populations. We evaluated age‐related differences in treatment and overall survival (OS). Methods Patients with FL‐HCC diagnosed from 2004 to 2021 were identified in the National Cancer Database. Demographic, tumor, and treatment characteristics were compared, and OS was assessed using Kaplan‐Meier analysis. Results Among 487 patients, 172 were children (< 18 years) and 315 were adults (≥ 18 years). Children more frequently underwent lymph node removal (80.0% vs 58.6%) and had higher positive‐margin rates (15.1% vs 6.7%). Five‐year OS was 70.5% in children versus 61.6% in adults. On multivariable analysis, adulthood (HR 1.38, 95% CI 1.00–1.89), metastasis at diagnosis (HR 3.47, 95% CI 2.39–5.02), and positive margins (HR 3.16, 95% CI 2.15–4.64) were associated with increased mortality. Conclusions Pediatric patients with FL‐HCC had superior OS despite similar disease burden. Positive margins were strongly associated with mortality, supporting efforts to achieve R0 resection.
EUVIMED